OTCMKTS:AXMP AXM Pharma (AXMP) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About AXM Pharma Stock (OTCMKTS:AXMP) Get AXM Pharma alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume300 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview AXM Pharma, Inc. (OTCMKTS:AXMP) is a clinical-stage specialty pharmaceutical company headquartered in New Jersey. The company is dedicated to identifying, acquiring and advancing novel dermatology products through late-stage clinical development. AXM Pharma’s core focus is on prescription treatments for skin and soft tissue infections, with a mission to address unmet medical needs in wound care and antimicrobial therapy. AXM Pharma’s lead asset is TCD-11091, a topical formulation designed to treat diabetic foot ulcers and other complicated skin infections. The company is conducting clinical trials to evaluate the safety and efficacy of this therapy, with the goal of demonstrating faster healing times and a favorable tolerability profile compared to existing treatment options. Development efforts are supported by preclinical and early-stage data suggesting broad-spectrum antimicrobial activity. In pursuit of global reach, AXM Pharma is exploring strategic collaborations and licensing agreements to facilitate future commercialization across the United States and select international markets. The company leverages partnerships with contract research organizations and specialty distributors to optimize its clinical trial execution and eventual product launch capabilities. AXM Pharma is guided by a management team with expertise in dermatology drug development, regulatory affairs and commercial strategy. By focusing on a targeted dermatology portfolio and streamlined clinical programs, the company aims to efficiently bring new treatments to patients living with challenging skin conditions.AI Generated. May Contain Errors. Read More Receive AXMP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AXM Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AXMP Stock News HeadlinesAXMP AXM Pharma, Inc.October 12, 2024 | seekingalpha.comGland Pharma Ltd GLANDFebruary 2, 2024 | morningstar.comMINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.September 17 at 2:00 AM | Traders Agency (Ad)Biomarin Pharmaceutical Inc BMRN Stock QuoteSeptember 19, 2023 | morningstar.comMShocker in the Senate: Big Pharma finds an unexpected friend in Bernie SandersJuly 3, 2023 | usatoday.comAXM Pharma Inc.March 21, 2023 | barrons.comThe Total Pharma TrackerOctober 26, 2022 | seekingalpha.comSee More Headlines AXMP Stock Analysis - Frequently Asked Questions How do I buy shares of AXM Pharma? Shares of AXMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/17/2025Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:AXMP CIKN/A Webwww.axmpharma.net Phone(702) 932-7980FaxN/AEmployees150Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (OTCMKTS:AXMP) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AXM Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AXM Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.